SubFlux · Advanced Delivery Technology
Delivery platform and evidence.
Differentiated Technology. Quantifiable Results. Commercially Ready.
Last updated 7 October 2026.
Wholesale gel-based peptides for ingestible, inhalable, and topical use, sold to brands, clinics, and distributors across the United States.
Composed exclusively of GRAS-certified ingredients and produced through a controlled no-heating process.
Technology platform and market advantage
Improved active ingredient uptake and bioavailability.
Compatible with water-soluble and fat-soluble compounds.
Engineered for direct physiological benefit at the cellular level.
Stable, customisable, and produced without heating to support ingredient integrity and long shelf life.
Multi-application delivery platform
One technology supports ingestible, inhalable, and topical delivery.
The overview reports no separate study for this route.
Rapid uptake and uniform absorption
Flexible respiratory delivery formats
The overview reports no separate study for this route.
Enhanced transdermal permeation
Clinical and laboratory evidence
Using 1300 KDa HA, the evaluation measured transdermal permeation across untreated, HA-only, unprocessed-component, and SubFlux RGJ26 conditions.
HCG (approximately 35 KDa) applied with SubFlux RGJ26 showed definitive presence in blood after 4 hours.
No structural damage or tissue morphology changes were observed across multiple compounds.
Application
Test formulation applied
Uptake
Absorption pathway assessed
Measurement
Blood, tissue, or permeation measured
Outcome
Safety and efficacy interpreted
Human clinical research
5-minute blood presence; effects sustained for 30 minutes.
Demonstrated rapid uptake with a measurable physiological response.
Randomised, double-blind, placebo-controlled
Improved blood cell counts and sleep quality, with no adverse effects reported.
Clinical evaluation
Improved haemoglobin saturation, red blood cell morphology, and rheology.
Priority sectors
Premium nutraceuticals
Improved bioavailability and multi-ingredient performance
Dermatology and anti-ageing
Enhanced transdermal delivery and formulation differentiation
Hormonal and peptide topical products
Support for larger-molecule transport
Rapid-response supplements
Fast uptake and measurable physiological response
Multi-ingredient complexes
Uniform absorption and coordinated delivery
Terms and materials
Samples are an evaluation quantity, quoted with the request. Pricing and minimums are confirmed on the quote.
Study documentation and technical materials are not posted on this site. Study summaries are shared with qualified partners after the request is reviewed.
FAQ
SubFlux RGJ26 is a proprietary delivery platform engineered to improve the uptake, absorption, and bioavailability of active ingredients. The SubFlux overview describes it as customisable, proprietary, clinically tested, and all-natural, composed exclusively of GRAS-certified ingredients and produced through a controlled no-heating process.
Qualified means a real business that will formulate, dispense, or resell. Personal-use buyers do not qualify.
Choose Order samples to open the same form. Samples are an evaluation quantity, quoted with the request.
Pricing and minimums are confirmed on the quote, after the request is reviewed. No prices or minimums are published on this site.
Partnership, licensing, technical collaboration
Study summaries are shared with qualified partners after the request is reviewed. A person at Geltides replies within two business days.